Table 2. Results of the quantitative viral DNA analysis to the positive patients copies/mL.
Groups | Statistical index | Pre-treatment | 7th day | 14th day | 28th day |
Corneal epithelium scrapings | Sample amount | 13 | 13 | 13 | 13 |
x±s | 390420.77±610715.88 | 529.23±1291.86 | 176.54±465.70 | 44.23±159.48 | |
P50 (P25-P75) | 2460 (2165-636500) | 0 (0-0) | 0 (0-0) | 0 (0-0) | |
Min. | 2030 | 0 | 0 | 0 | |
Max. | 2020000 | 3460 | 1580 | 575 | |
Incidence No. (rate) | 13 (100%) | 2 (15.38%) | 2 (15.38%) | 1 (7.69%) | |
Tears | Sample amount | 13 | 13 | 13 | 13 |
x±s | 893.85±2201.78 | 140.15±344.99 | 48.00±173.07 | 0.00±0.00 | |
P50 (P25-P75) | 0 (0-1150) | 0 (0-0) | 0 (0-0) | 0 (0-0) | |
Min. | 0 | 0 | 0 | 0 | |
Max. | 8010 | 1020 | 624 | 0 | |
Incidence No. (rate) | 4 (30.77%) | 2 (15.38%) | 1 (7.69%) | 0 (0.00%) |